Latest News

  • Kalbe Launches Vitek MS

    The Newest Technology on Clinical Microbiology to Increase Healthcare Services

    Thursday, March 28, 2013

    Jakarta, 28 March 2013 – PT Kalbe Farma Tbk (Kalbe) through its subsidiary PT Enseval Medika Prima (EMP)  is launching the Vitek Mass Spectrophotometry (Vitek MS) today, a medical device with a new technology in the microbiological test in the blood that would assist the enforcement of diagnosis and determination of the function of the use of antibiotics to be more precise and rational.

  • Kalbe Farma Celebrates World Kidney Day

    Kidney for Life – Stop Kidney Attack

    Sunday, March 17, 2013

    Jakarta, 17 March 2013 – PT Kalbe Farma Tbk (Kalbe)  through their Kalbe Ethical Customer Care (KECC) is holding healthy activities to celebrate World Kidney Day. This activity is is filled with health examinations consisting of blood pressure, blood sugar, cholesterol check, and a talk show with Dr. Tunggul Situmorang, Sp.PD-KGH (President Director of PGI Cikini Hospital, Jakarta) as guest speaker; with Kris Biantoro (Entertainer), who has been a kidney patient for 39 years. The event started at 08.00 am, took place at the Conference Room, Bintang Toedjoe; and was attended by 400 participants coming from numerous communities and individuals.

  • Kalbe Holds The Hydro Coco Cup National Futsal Tournamen 2013

    Kalbe for Healthier Indonesia

    Saturday, March 2, 2013

    Jakarta, 2 March 2013 – PT Kalbe Farma Tbk (Kalbe) through its Hydro Coco brand is holding the Hydro Coco Cup National Futsal Tournament. This tournament is a national-level futsal competition for high school students, to be held at the following seven cities: Jakarta, Makassar, Banjarmasin, Medan, Surabaya, Jogjakarta and Bandung. The Hydro Coco Cup Tournament is an agenda supported by the National Futsal Agency in developing and teaching teens, especially students, to get to know and play futsal properly and to encourage them to compete on international scene.

  • Indicative Net Profit for 2012 Increased by 17%

    Monday, February 4, 2013

    Jakarta, February 4, 2013 – PT Kalbe Farma Tbk and its subsidiaries (“Kalbe” or “the Company”) today announced the Company’s indicative performance (unaudited) for the year 2012. Indicative consolidated net profit reached Rp 1.73 Trillion for year 2012, an increase of approximately 17% compared to Rp 1.48 Trillion last year, mostly driven by strong top line growth and higher efficiency. Indicative earnings per share increased by approximately 17%, to Rp 36.9 per share from Rp 31.6 per share.

  • Kalbe’s Net Profit in First 9 Months of 2012 Surged by 16.7%

    Wednesday, October 31, 2012

    Jakarta, October 31, 2012 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced a consolidated (unaudited) net profit of Rp 1,243 Billion for the first 9 months of 2012, an increase of 16.7% compared to the same period last year of Rp 1,065 Billion, mostly driven by strong sales growth. Earnings per share increased by 16.7% from Rp 114 per share to Rp 133 per share.